Georgia's Online Cancer Information Center

Northside Hospital first in U.S. to use prostate cancer detection tool

10/13/2016, Ellie Hensley, Atlanta Business Chronicle

Northside Hospital is the first in the country to commercially use a tool to detect recurrent prostate cancer.

Axumin, which was recently approved by the U.S. Food and Drug Administration, is used in conjunction with positron emission tomography (PET) imaging on patients who are suspected to have had recurrent prostate cancer.

Traditional imaging agents contain glucose that is absorbed by cancerous cells, but prostate cancer has a low sensitivity to sugar. Axumin, by comparison, consists of synthetic amino acids that are designed specifically target prostate cancer cells.

Recurrence occurs in about one-third of prostate cancer patients. One-third of those who experience elevated PSA levels following prostatectomy or radiation therapy develop metastatic prostate cancer.

According to Northside, it diagnoses more prostate cancer cases than any other Georgia hospital.

Ellie Hensley is an entertainment, health care and general assignment reporter.

To view the original article, click here.

Media, News & Events

Georgia CORE is expanding our team

Georgia CORE is looking to fill the position of a part-time Chief Medical Officer.

5/21/2024

Georgia CORE awards Cancer Research Fund grant to two teams

Georgia CORE has awarded two teams a Collaborative Cancer Research Seed Grant from the Georgia Cancer Research Fund.

5/10/2024

Subscribe to Our Newsletter

Our email newsletter allows you to get the most up-to-date information right in your Inbox.

Subscribe Now